PolyActiva
Melbourne
About PolyActiva
PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.2M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2025)
- Website: polyactiva.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/polyactiva-78331 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.